Medications
Zafgen reports second death in key drug study
Zafgen Inc. on Wednesday reported a second patient death in an ongoing study of its potential treatment for a rare genetic disorder linked to obesity.
Dec 2, 2015
0
0
News tagged with biotechnology company
Medications
Bristol-Myers could spend $2.2B in deal with Dutch biotech (Update)
Bristol-Myers Squibb, one of the world's largest drugmakers, will team up with a Dutch biotechnology company whose first approved drug could cost more than $1 million.
Apr 6, 2015
0
6
Medications
Gilead's Harvoni accepted in Canadian health plan
Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.
Mar 24, 2015
0
3
Immunology
New treatments for hay fever and house dust mite allergy successfully tested
Researchers have successfully tested treatments for people with allergies to grasses and to dust mites.
Oct 3, 2013
0
0
Diseases, Conditions, Syndromes
New approach to celiac testing identifies more Australians at risk
Australian researchers have developed a new approach to detecting coeliac disease, revealing this immune disorder is far more common than previously recognised.
Aug 27, 2013
0
0
Medical research
Clearing the BAR to oral vaccines
A new technology under development by an academic–industry partnership protects oral vaccines from destruction by the digestive system.
Jun 10, 2013
0
0
Other
Irish biotech firm Elan rejects new Royalty bid
Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).
Jun 10, 2013
0
0
Medications
Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
May 13, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Genetics
US top court to hear case on gene patents
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Apr 13, 2013
0
0
